Assignee profile:

MorphoSys AG

City:

Planegg

Country:

Germany

Published Applications:

43

Last publication date:

2025-07-31

Patent Grants:

38

Last grant date:

2024-06-25

Top Inventors for applications by MorphoSys AG

These are the the leading inventors for applications assigned to MorphoSys AG:

Recent patent applications by MorphoSys AG

MorphoSys AG based in Planegg, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-31
US20250241859A1
Human necessities

ANTIBODY FORMULATIONS

#2 | 2024-12-19
US20240417455A1
Chemistry; metallurgy

TREATMENT FOR RHEUMATOID ARTHRITIS

#3 | 2024-01-18 ✅ Patent 12,018,072 granted on 2024-06-25
US20240018225A1
Chemistry; metallurgy

Antibodies specific for human complement C5A receptor (C5AR)

#4 | 2021-10-14 ✅ Patent 11,702,463 granted on 2023-07-18
US20210317190A1
Chemistry; metallurgy

Canine antibody libraries

#5 | 2021-09-23 ✅ Patent 11,939,395 granted on 2024-03-26
US20210292431A1
Chemistry; metallurgy

Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38

#6 | 2021-07-15 ✅ Patent 11,542,329 granted on 2023-01-03
US20210214435A1
Chemistry; metallurgy

Antibodies targeting Glycoprotein VI

#7 | 2021-05-06
US20210130451A1
Chemistry; metallurgy

TREATMENT FOR RHEUMATOID ARTHRITIS

#8 | 2020-12-24 ✅ Patent 11,352,620 granted on 2022-06-07
US20200399630A1
Chemistry; metallurgy

Peptide libraries

#9 | 2020-12-03 ✅ Patent 11,472,880 granted on 2022-10-18
US20200377594A1
Chemistry; metallurgy

Humanized antibodies for CD3

#10 | 2020-07-23 ✅ Patent 11,085,038 granted on 2021-08-10
US20200231963A1
Chemistry; metallurgy

Polypeptide library

#11 | 2020-07-16 ✅ Patent 11,014,978 granted on 2021-05-25
US20200223904A1
Chemistry; metallurgy

Canine antibody libraries

#12 | 2020-07-09 ✅ Patent 11,987,621 granted on 2024-05-21
US20200216529A1
Chemistry; metallurgy

Antibodies for IL-17C

#13 | 2020-03-12 ✅ Patent 11,591,406 granted on 2023-02-28
US20200079871A1
Chemistry; metallurgy

Treatment for multiple myeloma (MM)

#14 | 2019-11-14 ✅ Patent 11,254,734 granted on 2022-02-22
US20190345236A1
Chemistry; metallurgy

Fab molecules with a rodent hinge region and a non-rodent CH1 region

#15 | 2019-10-24 ✅ Patent 11,352,423 granted on 2022-06-07
US20190322742A1
Chemistry; metallurgy

Anti-CD19 antibody formulations

#16 | 2019-07-04 ✅ Patent 10,633,439 granted on 2020-04-28
US20190202906A1
Chemistry; metallurgy

Antibodies for IL-17C

#17 | 2019-03-14 ✅ Patent 11,059,902 granted on 2021-07-13
US20190077877A1
Chemistry; metallurgy

Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38

#18 | 2019-03-14 ✅ Patent 11,618,789 granted on 2023-04-04
US20190077875A1
Chemistry; metallurgy

Clinical assessment of M-protein response in multiple myeloma

#19 | 2019-02-28 ✅ Patent 10,815,297 granted on 2020-10-27
US20190062422A1
Chemistry; metallurgy

Antagonists of IL17C for the treatment of inflammatory disorders

#20 | 2019-02-14 ✅ Patent 10,533,057 granted on 2020-01-14
US20190048091A1
Chemistry; metallurgy

Treatment for multiple myeloma (MM)

#21 | 2019-02-14
US20190048071A1
Chemistry; metallurgy

ANTIBODIES FOR IL-17C

#22 | 2018-11-29 ✅ Patent 10,259,869 granted on 2019-04-16
US20180340024A1
Chemistry; metallurgy

Antibodies for IL-17C

#23 | 2018-08-16 ✅ Patent 10,913,792 granted on 2021-02-09
US20180230208A1
Chemistry; metallurgy

Treatment for rheumatoid arthritis

#24 | 2018-08-16 ✅ Patent 11,224,654 granted on 2022-01-18
US20180228893A1
Human necessities

Combinations and uses thereof

#25 | 2018-06-07 ✅ Patent 10,617,691 granted on 2020-04-14
US20180153892A1
Human necessities

Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof

#26 | 2018-05-17 ✅ Patent 10,774,154 granted on 2020-09-15
US20180134807A1
Chemistry; metallurgy

Complex-specific antibodies and antibody fragments and its use

#27 | 2018-03-01 ✅ Patent 10,081,675 granted on 2018-09-25
US20180057581A1
Chemistry; metallurgy

Antibodies targeting M-CSF

#28 | 2018-01-25 ✅ Patent 10,308,722 granted on 2019-06-04
US20180022823A1
Chemistry; metallurgy

Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide

#29 | 2017-08-03 ✅ Patent 10,647,757 granted on 2020-05-12
US20170218048A1
Chemistry; metallurgy

Collection and methods for its use

#30 | 2017-06-29 ✅ Patent 10,919,955 granted on 2021-02-16
US20170183395A1
Chemistry; metallurgy

Rodent combinatorial antibody libraries

#31 | 2017-06-15 ✅ Patent 10,822,604 granted on 2020-11-03
US20170166886A1
Chemistry; metallurgy

Peptide libraries

#32 | 2017-05-04 ✅ Patent 10,273,285 granted on 2019-04-30
US20170121388A1
Chemistry; metallurgy

Fusion proteins and uses thereof

#33 | 2017-04-13 ✅ Patent 10,836,829 granted on 2020-11-17
US20170101473A1
Chemistry; metallurgy

Anti-WT1/HLA-specific antibodies

#34 | 2016-06-30 ✅ Patent 10,005,840 granted on 2018-06-26
US20160185867A1
Chemistry; metallurgy

Method for treatment of osteoarthritis with C-Fms antagonists

#35 | 2016-04-28 ✅ Patent 9,758,590 granted on 2017-09-12
US20160115243A1
Chemistry; metallurgy

Anti-CD38 human antibodies and uses thereof

#36 | 2016-04-14 ✅ Patent 9,856,316 granted on 2018-01-02
US20160102142A1
Chemistry; metallurgy

Antibodies targeting M-CSF

#37 | 2016-03-17 ✅ Patent 10,184,005 granted on 2019-01-22
US20160075796A1
Chemistry; metallurgy

Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38

#38 | 2015-12-24 ✅ Patent 9,873,733 granted on 2018-01-23
US20150368323A1
Chemistry; metallurgy

Anti-staphylococcal antibodies

#39 | 2014-11-27 ✅ Patent 9,689,014 granted on 2017-06-27
US20140349343A1
Chemistry; metallurgy

Use of lysozyme as a tag

#40 | 2014-06-12 ✅ Patent 9,624,293 granted on 2017-04-18
US20140163208A1
Chemistry; metallurgy

Collection and methods for its use

#41 | 2013-10-17 ✅ Patent 9,193,799 granted on 2015-11-24
US20130273072A1
Chemistry; metallurgy

Fully human therapeutic antibodies specific for human CD38

#42 | 2007-12-20
US20070292947A1
Chemistry; metallurgy

NOVGEL METHODS FOR DISPLAYING (POLY)PEPTIDES/PROTEINS ON BACTERIOPHAGE PARTICLES VIA DISULFIDE BONDS

#43 | 2005-03-17 ✅ Patent 7,785,859 granted on 2010-08-31
US20050058984A1
Chemistry; metallurgy

Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds

Also check out MorphoSys AG's (Planegg, Germany) applicant profile with 46 patent applications submitted.

AssigneeID:

132677 ⎘